drugset / Trial / NCT00796133
A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women
RandomizedCrossoverSingle-blindTreatment
Summary
This is a Phase 2, dose-finding, cross-over study for the purposes of evaluating the effect of a NES/E2 transdermal gel delivery on ovulation suppression in normal ovulating women.
Timeline
- Start
- 2008-11
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Estradiol | Other / unclassified | 0.5 mg | Other |
| Comparator | Estradiol | Other / unclassified | 1 mg | Other |
| Comparator | Estradiol | Other / unclassified | 1.5 mg | Other |
| Comparator | Segesterone Acetate | Small molecule | 1.5 mg | Other |
| Comparator | Segesterone Acetate | Small molecule | 3 mg | Other |
| Comparator | Segesterone Acetate | Small molecule | 4.5 mg | Other |